Lv11
28 积分 2026-01-15 加入
Multivalent, asymmetric IL-2–Fc fusions show enhanced selectivity for regulatory T cells
39分钟前
待确认
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
1小时前
已完结
A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo
1小时前
已完结
An engineered IL-2 partial agonist promotes CD8+ T cell stemness
3天前
已完结
皖公网安备34019202002308
